Table 1.
Characteristics | No of patients (%) |
---|---|
Age |
|
Median |
44 |
Range |
37-66 |
Gender |
|
Male |
12 (80.0%) |
Female |
3 (20.0%) |
Histology |
|
WHO I |
0 (0.0%) |
WHO II/III |
15 (100.0%) |
T stage* |
|
T1 |
1 (6.7%) |
T2 |
5 (33.3%) |
T3 |
9 (60.0%) |
T4 |
0 (0.0%) |
N stage* |
|
N0 |
3 (20.0%) |
N1 |
7 (46.7%) |
N2 |
4 (26.7%) |
N3 |
1 (6.7%) |
Clinical stage* |
|
I |
1 (6.7%) |
II |
2 (13.3%) |
III |
11 (73.3%) |
IV |
1 (6.7%) |
Chemotherapy |
|
No |
3 (20.0%) |
Yes | 12 (80.0%) |
*According to the 7th American Joint Commission on Cancer/Union for International Cancer Control staging system.